Status:

ACTIVE_NOT_RECRUITING

Cerebral Cortical Influences on Autonomic Function

Lead Sponsor:

David Levinthal

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Healthy Subjects

Functional Dyspepsia

Eligibility:

All Genders

21-60 years

Phase:

NA

Brief Summary

This is an exploratory neurophysiological study that will determine the impact of non-invasive brain stimulation on autonomic regulation, with a focus on gastrointestinal function. These studies shoul...

Detailed Description

The overall goal of this study is to determine the impact of non-invasive brain stimulation on autonomic function in human subjects without functional gastrointestinal disorders and in subjects with I...

Eligibility Criteria

Inclusion

  • Adults between age 21 and 60
  • Participants without gastrointestinal symptoms (Healthy Subjects)
  • Participants with gastrointestinal symptoms compatible with functional dyspepsia (FD) and or irritable bowel syndrome (IBS)

Exclusion

  • history of myocardial infarction, supplemental oxygen requirement, or diabetes
  • history of chronic gastrointestinal symptoms (for healthy subjects only)
  • history of gastric surgery
  • psychosis or altered cognitive status
  • history of head injury, metal in the skull, stroke, or a history of seizures
  • implantable devices, such as a pacemaker or nerve stimulator
  • current use of the following medications or use of substances which are known to lower the seizure threshold: amitriptyline (Elavil), nortriptyline (Pamelor), imipramine (Tofranil), doxepin (Sinequan), clozapine (Clozaril), chlorpromazine (Thorazine), amphetamines or methamphetamine, Ecstasy, Ketamine, Angel Dust/phencyclidine (PCP), cocaine, or 3 or more alcoholic drinks per day
  • pregnancy
  • Body-Mass-Index (BMI) \> 35

Key Trial Info

Start Date :

April 5 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 3 2026

Estimated Enrollment :

244 Patients enrolled

Trial Details

Trial ID

NCT03869372

Start Date

April 5 2019

End Date

October 3 2026

Last Update

October 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15232